Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This 17-country phase 2 double-blind placebo-controlled trial enrolled people with biopsy-confirmed NASH, stage 1 to 3 fibrosis, body mass index above 25 kg/m2 (the overweight threshold), HbA1c at or below 10% and NAFLD Activity Score at or above 4
For payers and insurers Update approved drug lists and budget impact models
For a 248-pound individual, that equals 71.2 pounds lost
Eden's semaglutide program offers a more affordable way to access GLP-1-based care than paying typical list prices for brand-name medications out of pocket, with comprehensive support that goes beyond just medication delivery
Get in touch today to find out more or for your free consultation The NuSkin Academy Scale your Aesthetics Business with our advanced In-Person and Online Aesthetics training courses
NEW YORK, NY, Jan
